In detail, Mdivi-1 inhibits the self-renewal and tumor initiation capacities of CD133+CD15+ brain tumor-initiating cells (BTICs) [92] and decreases the levels of stemness genes in EpCAM+CD133+ liver cancer stem cells (LCSCs) [91]. The gene discussed is PROM1; the disease is liver cancer.